U4F-52482-82921 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-28
Dose 1 — Pfizer-BioNTech
2020-12-31
Registered in v-safe
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-04
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-11
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-18
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-01-21
Dose 2 — Pfizer-BioNTech
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Swelling, Itching · Headache, Muscle or body aches

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Swelling, Itching · Fatigue or tiredness, Diarrhea

Adult check-in
2021-01-28
Health check-in — day 7, dose 2
Feeling: Good · Site: Itching · Fatigue or tiredness, Nausea

Adult check-in
2021-02-04
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-13
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-18
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-27
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-22
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-22
Survey response — 6 months, dose 2
MedDRA: Gestational diabetes — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Gestational diabetes

MedDRA releases: 2024-11 · check-in free text available
2021-07-22
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-26
Call 1 — Could Not Reach Participant
2021-07-29
Call 2 — Could Not Reach Participant
2022-01-21
Survey response — 12 months, dose 2
MedDRA: Hypertension, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: High blood pressure · Healthcare visit (other): Still in progress

MedDRA releases: 2024-11 · check-in free text available
2022-01-21
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2022-01-24
Call 1 — Could Not Reach Participant
2022-01-27
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-28	Pfizer-BioNTech
2	2021-01-21	Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-07-22

Symptoms: Gestational diabetes

Release 11 — 12 months, dose 2

2022-01-21

Symptoms: High blood pressure

Healthcare visit (other): Still in progress

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Gestational diabetes	·	·	✓
SD	Hypertension	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release